SAN DIEGO (AP) _ Kura Oncology Inc. (KURA) on Tuesday reported a loss of $16.4 million in its third quarter.
On a per-share basis, the San Diego-based company said it had a loss of 36 cents.
The results surpassed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 39 cents per share.
Kura Oncology shares have risen roughly 6% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $14.87, a climb of 31% in the last 12 months.